School of Regulation and Global Governance, Australian National University, Canberra, ACT, Australia.
Int J Health Policy Manag. 2020 Mar 1;9(3):124-127. doi: 10.15171/ijhpm.2019.105.
It is a well-documented fact that transnational corporations engaged in the production and distribution of health-harmful commodities have been able to steer policy approaches to address the associated burden of non-communicable diseases (NCDs). While the political influence that corporations wield stems in part from significant financial resources, it has also been enabled and magnified by what has been referred to as global health's neoliberal deep core, which has subjected health policy to the individualisation of risk and responsibility and the privileging of market-based policy responses. The accompanying perspective article from Lencucha and Thow draws attention to neoliberalism in the NCD space and the way it has historically structured patterns of thinking and doing that foreground economic interests over health considerations. In this commentary, we explore how shifting from a focus on material power to discursive power creates space to see the NCD agenda as a battle of economic ideas as well as dollars, and consequently the importance of public health engagement in the next vision for the economy.
跨国公司从事有害健康商品的生产和销售，这是一个有据可查的事实，它们能够引导政策措施来应对非传染性疾病的相关负担。尽管企业所行使的政治影响力部分源于其大量的财政资源，但这也得益于所谓的全球卫生新自由主义核心，该核心将卫生政策置于风险和责任的个体化以及基于市场的政策应对的优先地位。伦丘卡和索的随附观点文章提请注意非传染性疾病领域的新自由主义以及它在历史上构建思维和行动模式的方式，这种模式将经济利益置于健康考虑之上。在这篇评论中，我们探讨了从关注物质权力转向话语权力如何为将非传染性疾病议程视为一场经济理念以及美元的较量创造空间，以及公共卫生部门参与制定下一个经济愿景的重要性。
